The Discounted Cash Flow (DCF) valuation of Cyclo Therapeutics Inc (CYTH) is (591.49) USD. With the latest stock price at 0.72 USD, the upside of Cyclo Therapeutics Inc based on DCF is -82183.6%.
Based on the latest price of 0.72 USD and our DCF valuation, Cyclo Therapeutics Inc (CYTH) is a sell. selling CYTH stocks now will result in a potential gain of 82183.6%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.1% - 7.4% | 6.7% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (1,515.08) - (370.96) | (591.49) |
| Upside | -210352.2% - -51579.1% | -82183.6% |